Cetera Investment Advisers’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.14M | Sell |
9,060
-2,797
| -24% | -$352K | ﹤0.01% | 2259 |
|
|
2025
Q1 | $1.31M | Buy |
11,857
+3,688
| +45% | +$408K | ﹤0.01% | 2052 |
|
|
2024
Q4 | $1.12M | Buy |
8,169
+2,593
| +47% | +$354K | ﹤0.01% | 2092 |
|
|
2024
Q3 | $642K | Sell |
5,576
-1,536
| -22% | -$177K | ﹤0.01% | 2450 |
|
|
2024
Q2 | $979K | Buy |
7,112
+519
| +8% | +$71.5K | ﹤0.01% | 2090 |
|
|
2024
Q1 | $909K | Buy |
+6,593
| New | +$909K | ﹤0.01% | 2152 |
|
|
2023
Q2 | – | Sell |
-2,592
| Closed | -$262K | – | 2247 |
|
|
2023
Q1 | $262K | Buy |
2,592
+610
| +31% | +$61.7K | ﹤0.01% | 1782 |
|
|
2022
Q4 | $237K | Buy |
+1,982
| New | +$237K | ﹤0.01% | 1803 |
|